| 6981 |
Roles and Responsibilities of ASHAs/CVs under the 100 Days Campaign |
English |
Not specified |
|
Off |
| 6980 |
Nikshay Information EcoSystem |
English |
Not specified |
|
Off |
| 6979 |
Nikshay Information EcoSystem |
English |
Not specified |
|
Off |
| 6978 |
Nikshay Information EcoSystem |
English |
Not specified |
|
Off |
| 6977 |
Nikshay Information EcoSystem |
English |
Not specified |
|
Off |
| 6976 |
Task List on Ni-kshay |
English |
Not specified |
|
Off |
| 6975 |
Recording, reporting and Monitoring at the Block level during the campaign |
English |
Not specified |
|
Off |
| 6974 |
Roles and Responsibilities of MO-TC/BMO under the 100 Days campaign |
English |
Not specified |
|
Off |
| 6971 |
Roles and Responsibilities of MO-PHI under the 100 Days Campaign |
English |
Not specified |
|
Off |
| 6970 |
Goal and Key Strategies of the 100 Days Campaign |
English |
Not specified |
|
Off |
| 6969 |
100 Days Campaign |
English |
Not specified |
|
Off |
| 6968 |
Key Strategies of the 100 Days Campaign |
English |
Not specified |
|
Off |
| 6967 |
Introduction to 100 Days Campaign |
English |
Not specified |
|
Off |
| 6961 |
2024 Updates in DR-TB Management |
English |
Not specified |
|
Off |
| 6959 |
Management of ADRs - DR-TB Treatment |
English |
Not specified |
|
Off |
| 6957 |
Management DR-TB in Special Situations - People with anemia |
English |
Not specified |
|
Off |
| 6956 |
Principles of Switching to BPal from Shorter Oral Regimen |
English |
Not specified |
|
Off |
| 6955 |
Management of DR-TB Treatment interruptions |
English |
Not specified |
|
Off |
| 6952 |
Ambulatory care for DR-TB patients |
English |
Not specified |
|
Off |
| 6951 |
Reconstitution of PwB for BPaLM regimen |
English |
Not specified |
|
Off |
| 6949 |
Scenarios for deciding for DR-TB Regimen |
English |
Not specified |
|
Off |
| 6945 |
Management DR-TB in Special Situations |
English |
Not specified |
|
Off |
| 6943 |
Management DR-TB in Special Situations - People with Diabetes Mellitus |
English |
Not specified |
|
Off |
| 6941 |
Refreshing BDQ course after switching between regimens |
English |
Not specified |
|
Off |
| 6940 |
Management DR-TB in Special Situations - People with Liver disease |
English |
Not specified |
|
Off |
| 6938 |
Principles of Switching from BpalL/ Shorter Oral Regimen to Longer Oral Regimen |
English |
Not specified |
|
Off |
| 6937 |
Management DR-TB in Special Situations - different age groups |
English |
Not specified |
|
Off |
| 6935 |
Management of DR-TB in people living with HIV |
English |
Not specified |
|
Off |
| 6933 |
TB Disease Severity considerations for Management |
English |
Not specified |
|
Off |
| 6932 |
Regimen Modification of Shorter Oral MDR/RR regimen containing Bdq and Lnz |
English |
Not specified |
|
Off |
| 6931 |
Follow-up monitoring of modified shorter oral MDR/RR-TB regimen with Lzd |
English |
Not specified |
|
Off |
| 6928 |
Issue of BPaLM regimen PwBs |
English |
Not specified |
|
Off |
| 6927 |
Packaging of BPaLM regimen and PwB |
English |
Not specified |
|
Off |
| 6926 |
Discordance resolution in RR between LPA and NAAT |
English |
Not specified |
|
Off |
| 6925 |
Follow-up monitoring of BPaLM |
English |
Not specified |
|
Off |
| 6924 |
Screening of patients on BPaLM regimen for Linezolid toxicity |
English |
Not specified |
|
Off |
| 6923 |
Extension criterion for BPaLM regimen |
English |
Not specified |
|
Off |
| 6922 |
Implementation Consideration for BPaLM regimen |
English |
Not specified |
|
Off |
| 6921 |
Regimen modification for patients on BPaLM regimen |
English |
Not specified |
|
Off |
| 6920 |
Management of BPaLM ineligible patients |
English |
Not specified |
|
Off |
| 6919 |
Overview of Treatment Course for patients on BPaLM regimen |
English |
Not specified |
|
Off |
| 6918 |
Pregnancy and Lactation |
English |
Not specified |
|
Off |
| 6916 |
Evidence for the efficacy of BPaL regimen in DR-TB |
English |
Not specified |
|
Off |
| 6915 |
Peripheral neuropathy screening tool |
English |
Not specified |
|
Off |
| 6914 |
Long term follow-up for DR-TB treatment |
English |
Not specified |
|
Off |
| 6913 |
Treatment initiation for MDR/RR-TB cases |
English |
Not specified |
|
Off |
| 6912 |
Integrated DR-TB Algorithm |
English |
Not specified |
|
Off |
| 6911 |
Peripheral Neuropathy |
English |
Not specified |
|
Off |
| 6909 |
DAIDS scale for assessment of Peripheral Neuropathy |
English |
Not specified |
|
Off |
| 6908 |
Rationale for continuation of Moxifloxacin in BPaLM regimen irrespective of FQ resistance |
English |
Not specified |
|
Off |
